9ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
Program
Schedule
12.10.2013
13.10.2013
14.10.2013
15.10.2013
Scientific Committee
Media
Photos
Videos
Downloads
Acknowledgements
Sponsors
Other Archives
ISHL13
ISHL12
Update on Hodgkin Lymphoma
ISHL11
ISHL10
ISHL9
ISHL8
ISHL7
Back to video list
Can we improve ABVD?
Speaker
Stephen Ansell
Session
Advanced Stages
Others Talks of this Session
Risk-adapted therapy in advanced stage Hodgkin Lymphoma: An Update
Impact of dose reductions of bleomycin and vincristine in patients with advanced Hodgkin Lymphoma treated with BEACOPP polychemotherapy: A comprehensive analysis of the German Hodgkin Study Group (GHSG) HD12 and HD15 trials
Standard ABVD vs. escalated BEACOPP in stage III – IV low risk Hodgkin Lymphoma (IPS 0-2): the Lymphoma Study Association (LYSA) H34 trial
This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies.
Learn more
Got it!